Imatinib mesylate and cardiac function

被引:0
|
作者
Luciano, L. [1 ]
Cerchione, C. [1 ]
Becchimanzi, C. [1 ]
Pane, F. [1 ]
Rotoli, B. [1 ]
机构
[1] Univ Naples Federico 2, Div Hematol, Naples, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:182 / 182
页数:1
相关论文
共 50 条
  • [41] FDA licences imatinib mesylate for CML
    Habeck, M
    LANCET ONCOLOGY, 2002, 3 (01): : 6 - 6
  • [42] Imatinib mesylate causes hypopigmentation in the skin
    Tsao, AS
    Kantarjian, H
    Cortes, J
    O'Brien, S
    Talpaz, M
    CANCER, 2003, 98 (11) : 2483 - 2487
  • [43] 口服抗癌新药:imatinib mesylate
    张延军
    韩丽萍
    吴新荣
    季波
    广东药学院学报, 2002, (04) : 313 - 316
  • [44] Imatinib Mesylate (Gleevec) induced hepatitis
    Rudraraju, M
    Chaudary, N
    Fazili, D
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S258 - S258
  • [45] Imatinib mesylate - synthesis and preparation of polymorphs
    Szczepek, Wojciech J.
    PRZEMYSL CHEMICZNY, 2006, 85 (05): : 306 - 309
  • [46] Hypocalcemia in patients taking imatinib mesylate
    Quayle, FJ
    Cohen, MS
    DeBenedetti, MK
    Foster, L
    Fracasso, PM
    Moley, JF
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 14 - 14
  • [47] Periorbital edema secondary to imatinib mesylate
    McClelland, Collin M.
    Harocopos, George J.
    Custer, Philip L.
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 427 - 431
  • [48] Hypersensitivity pneumonitis related to imatinib mesylate
    Bergeron, A
    Bergot, E
    Vilela, G
    Ades, L
    Devergie, A
    Espérou, H
    Socié, G
    Calvo, F
    Gluckman, E
    Ribaud, P
    Rousselot, P
    Tazi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4271 - 4272
  • [49] Imatinib mesylate in thymic epithelial malignancies
    Giovannella Palmieri
    Mirella Marino
    Carlo Buonerba
    Piera Federico
    Salvatore Conti
    Michele Milella
    Luigi Petillo
    Amelia Evoli
    Maurizio Lalle
    Anna Ceribelli
    Gerardina Merola
    Elide Matano
    Stefano Sioletic
    Sabino De Placido
    Giuseppe Di Lorenzo
    Vincenzo Damiano
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 309 - 315
  • [50] Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis
    Hasselbalch, HC
    Bjerrum, OW
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Birgens, H
    Therkildsen, MH
    Ralfkiær, E
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (04) : 238 - 242